at://
/
app.bsky.feed.post
/
3mnhjfrwwek2f
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Lucienne Chatenoud (INEM) presents the use of non-mitogenic anti-CD3 antibodies in type 1 diabetes. The goal? Modulating the immune response to protect the pancreas and slow disease progression. 🩸 #Diabetes #Immunotherapy
8d
Institut Imagine
